NEK6 identified as a novel therapeutic target in ALS and FTD
Sep. 20, 2022
Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are two devastating neurodegenerative diseases, with clinical, pathological and genetic overlap, without effective therapy.